|Articles|January 1, 2017
January 2017: Small-Company Attention, Big-Company Resources
Author(s)CuraScriptSD
Gayle Johnston explains what makes CuraScript SD uniquely able to serve its broad range of customers.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly’s Foundayo and Lower-Dose Zepbound Helped Maintain Weight Loss in Patients Switching from Injectables
2
Beyond the Molecule: The New Competitive Battlefield in Oncology
3
FDA Approves Beqalzi for Relapsed or Refractory Mantle Cell Lymphoma, Inqovi in Combination with Venetoclax
4
Pharmaceutical Executive Daily: FDA Approves Beqalzi and Inqovi
5